Andere Sprachen Novo Nordisk A/S

Aktien

A3EU6F

DK0062498333

NOVO B

Pharmazeutika

Markt geschlossen - Nasdaq Copenhagen Andere Börsenplätze 17:20:00 12.12.2025			% 5 Tage	Veränd. 1. Jan.
321,15 ^DKK	+0,45 %		+3,73 %	-48,55 %

17:18	Europäische Aktien als American Depositary Receipts in den USA am Freitag schwächer - Wochentrend bleibt positiv	MT
17:14	Novo Nordisk ist nur einem begrenzten Risiko durch Lillys Retatrutide ausgesetzt

Andere Sprachen

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Shares Still Up This Week	17:18
Novo Nordisk faces limited risk from Lilly's Retatrutide	17:14
Novo Nordisk Receives European Regulator's Positive Opinion for Higher Dose of Wegovy	15:59
Avis positif pour une dose plus élevée de Wegovy (Novo Nordisk)	15:42
EU Panel Backs Higher Dose of Novo Nordisk's Weight-loss Drug Wegovy	15:37
EU drugs regulator backs higher dose of Novo's Wegovy	15:10
Ozempic launches in India at $24 a week as Novo targets booming market	15:07
Novo Nordisk A/S: More efficacious dose of Wegovy® recommended by the European Medicines Agency can help people with obesity achieve an average of 20.7% weight loss	14:58
EU committee backs extending use of Lilly's diabetes drug for children aged 10 and above	14:51
Eli Lilly Could Get FDA Decision for Weight-Loss Pill Orforglipron by March 2026	13:27
Weight-loss drug developers line up to tap lucrative market as competition heats up	13:06
Health Rounds: Pfizer drug delays progression of advanced breast cancer in trial	13:00
Novo Nordisk Reportedly Launches Ozempic in India	12:19
US FDA brass pushed internally for speedier Lilly weight-loss pill verdict	12:04
Alzheimer's drug hunt learns from cancer fight's multi-target playbook	12:02
Novo Nordisk A/S : Rules of Procedure for the Board of Directors ( rules of procedure 2025 )	10:13
Novo Nordisk A/S : Charter of the Chair Committee of the Board of Directors ( charter chair committee 2025 )	10:13
Novo Nordisk A/S : Charter of the Audit Committee of the Board of Directors ( charter audit committee 2025 )	10:13
Novo Nordisk A/S : Charter of the People & Governance Committee of the Board of Directors ( charter of people and governance committee 2025 )	10:13
Novo Nordisk A/S : Charter of the Remuneration Committee of the Board of Directors ( charter remuneration committee 2025 )	10:13
Novo Nordisk A/S : Charter of the Research & Development Committee of the Board of Directors ( charter r and d committee 2025 )	10:13
Bourse : Eiffage chasse Edenred du CAC 40, un nouveau capitaine chez Sopra Steria et Lululemon qui se réveille	08:48
Ozempic launches in India at $24 a week as Novo targets booming diabetes market	08:31
En Bourse, la Fed ramène un peu de sérénité	07:58
Novo Nordisk -Ozempic 1 mg dose priced in India at 11,175 rupees per month	07:55